Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease

Silvia Svegliati, Attilio Olivieri, Nadia Campelli, +8

Blood

First Report of the Gimema LAL1811 Phase II Prospective Study of the Combination of Steroids with Ponatinib As Frontline Therapy of Elderly or Unfit Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Giovanni Martinelli, Alfonso Piciocchi, Cristina Papayannidis, +32

Blood

INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia

Giovanni Martinelli, Cristina Papayannidis, Alfonso Piciocchi, +35

Blood Advances

Hematological MalignancyFrontline TherapyFatal TeaesOncologyCore Phase +13

Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T‐cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study

Anna Candoni, Davide Lazzarotto, Felicetto Ferrara, +30

American Journal of Hematology

Cell TherapyMixed-phenotype Acute LeukemiaCell Replacement TherapyNelarabine Salvage TherapyImmunotherapy +19

Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA

Attilio Olivieri, Guido Gini, Caterina Bocci, +13

The Oncologist

Quality of life and physicians' perception in myelodysplastic syndromes.

Carlo Finelli, Valeria Santini, Antonella Poloni, +19

PubMed

Quality Of LifeFamily MedicineLife AssessmentAplastic AnemiaHematological Malignancy +14

Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the Campus ALL Network

Maria Ilaria Del Principe, Elisa Buzzatti, Alfonso Piciocchi, +22

Haematologica

Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial

Renato Bassan, Sabina Chiaretti, Irene Della Starza, +29

Blood Advances

Mixed-phenotype Acute LeukemiaPathologyPegaspargase-modified Risk-oriented ProgramLal1913 TrialPharmacotherapy +18

Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome

Antonella Poloni, Federica Serrani, Eleonora Berardinelli, +7

Leukemia Research

Hematological MalignancyChromatinPrognosis MarkersMedicineMixed-phenotype Acute Leukemia +10

Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes

Antonella Poloni, Gaia Goteri, Antonio Zizzi, +14

European Journal Of Haematology